Deardorf Caren
Insider CIK 1871152 · CRNX Director · MGTA Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 35,000 | $65.70 | $2.30M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 4,375 | $66.71 | $291.9K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 16,300 | $85.00 | $1.39M | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 4,375 | $66.71 | $291.9K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 35,000 | $65.70 | $2.30M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 16,300 | $85.00 | $1.39M | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-06-18 | 2026-06-22 | 9,730 | — | $0 | 9,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-06-18 | 2026-06-22 | 5,925 | — | $0 | 22,225 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-06-11 | 2025-06-13 | 10,350 | — | $0 | 10,350 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-06-11 | 2025-06-13 | 6,900 | — | $0 | 16,300 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-06-07 | 2024-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-06-07 | 2024-06-11 | 3,400 | — | $0 | 9,400 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-06-16 | 2023-06-21 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-06-16 | 2023-06-21 | 6,000 | — | $0 | 6,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award | 2022-11-30 | 2022-12-02 | 3,000 | $0.94 | $2.8K | 19,762 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2022-08-01 | 2022-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-06-17 | 2022-06-21 | 4,375 | — | $0 | 4,375 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award | 2022-05-31 | 2022-06-06 | 3,000 | $0.99 | $3.0K | 16,762 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-03-11 | 2022-04-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-03-11 | 2022-03-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2022-02-15 | 2022-02-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | S Sale | 2021-09-16 | 2021-09-20 | 6,238 | $6.73 | $42.0K | 13,762 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award | 2021-09-14 | 2021-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2021-07-06 | 2021-07-08 | 200,000 | — | $0 | 200,000 | SEC↗ |